"The decline in the number of revascularization procedures may be attributed to a variety of factors, including changes in medical therapy and PCI technology," says Cardiac Data Solutions founder April Simon, RN, who was one of the researchers. "From a quality perspective, it will be important to monitor patient outcomes for facilities and clinicians to determine if the decline in volumes impacts the ability to gain the necessary proficiency and expertise to maintain the current trend of improved outcomes despite increased patient severity."
The research studied all Medicare beneficiaries undergoing CABG or PCI, with the exception of those with any concomitant valve surgery, in a U.S. hospital between October 1, 2002 and September 30, 2006.
In addition to Simon, the researchers included Phillip P. Brown, MD, cardiovascular surgeon (retired) and past chairman, Department of Surgery, Centennial Medical Center; Aaron Kugelmass, MD, director of Cardiac Catheterization at Henry Ford Hospital; David J. Cohen, MD, interventional cardiologist and director, Cardiovascular Research, Mid America Heart Institute, St. Luke's Hospital; Matthew R. Reynolds, MD, electrophysiologist and director, Economics and Quality of Life Core Lab, Harvard Clinical Research Institute; and Steven D. Culler, PhD, associate professor, Rollins School of Public Health,
About Cardiac Data Solutions, Inc. (CDS)
Founded in 1999, Cardiac Data Solutions, Inc. (CDS) provides consultation services, data analysis, clinical benchmarks, management tools, research support services and leadership training to hospitals, physicians, payors, manufacturers and the financial community. CDS is focused solely on the cardiovascular market with the primary mission of supporting and improving clinical and business decisions to improve the quality of patient care. Using a proprietary data analysis tool with compreh
|SOURCE Cardiac Data Solutions, Inc.|
Copyright©2009 PR Newswire.
All rights reserved